Laurent Pelletier Selected Research

N(6)-methyldeoxyadenosine

5/2003

Induction of neurite outgrowth in PC12 cells by the bacterial nucleoside N6-methyldeoxyadenosine is mediated through adenosine A2a receptors and via cAMP and MAPK signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Pelletier Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 05/2003
5	Glioma (Gliomas) 01/2022 - 01/2011
4	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2011
2	Brain Neoplasms (Brain Tumor) 12/2017 - 01/2013
1	Gliosarcoma 01/2022
1	Atrophy 11/2020
1	Muscle Weakness 11/2020
1	Central Core Myopathy (Central Core Disease) 11/2020
1	Muscular Diseases (Myopathy) 11/2020
1	Cardiomyopathies (Cardiomyopathy) 12/2017
1	Carcinoma (Carcinomatosis) 10/2017
1	Ovarian Neoplasms (Ovarian Cancer) 10/2017
1	Peritoneal Neoplasms 10/2017
1	Breast Neoplasms (Breast Cancer) 09/2013
1	Inflammation (Inflammations) 01/2013
1	Oligodendroglioma 01/2011
1	Meningioma (Meningiomas) 02/2010
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2004

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2004
2	Small Interfering RNA (siRNA)IBA 10/2017 - 12/2015
1	Therapeutic UsesIBA 01/2022
1	Meloxicam (Mobic)FDA LinkGeneric 01/2022
1	Tamoxifen FDA LinkGeneric 11/2020
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 11/2020
1	Calcium Channels (Calcium Channel)IBA 11/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Cell ExtractsIBA 01/2020
1	Monoclonal AntibodiesIBA 05/2018
1	TubulinIBA 12/2017
1	LuciferasesIBA 10/2017
1	atelocollagenIBA 10/2017
1	Ephrin-B3 (Ephrin B3)IBA 04/2017
1	LigandsIBA 04/2017
1	EphA4 ReceptorIBA 04/2017
1	Casein Kinase II (Casein Kinase 2)IBA 12/2015
1	Bevacizumab (Avastin)FDA Link 09/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	HMGB1 Protein (HMG1)IBA 01/2013
1	C-Type Lectins (C-Type Lectin)IBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	cadherin 5IBA 01/2013
1	Metalloproteases (Metalloproteinases)IBA 01/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013
1	NAD (NADH)IBA 01/2011
1	MicroRNAs (MicroRNA)IBA 01/2011
1	Sirtuin 1IBA 01/2011
1	malic acid (malate)IBA 01/2011
1	Aspartic Acid (Aspartate)FDA Link 01/2011
1	Tissue ExtractsIBA 02/2010
1	VimentinIBA 02/2010
1	RNA (Ribonucleic Acid)IBA 09/2004
1	N(6)-methyldeoxyadenosineIBA 05/2003

Therapy/Procedure

5	Radiotherapy 01/2022 - 01/2013
4	Synchrotrons 01/2022 - 01/2013
1	Lasers (Laser) 01/2020
1	Therapeutics 12/2015